Genmab

company

About

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.

  • 501 - 1000

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$40.50M
Industries
Biotechnology,Health Care,Manufacturing,Medical
Founded date
Jan 1, 1999
Number Of Employee
501 - 1000
Operating Status
Active

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$42.50M
Genmab has raised a total of $42.50M in funding over 2 rounds. Their latest funding was raised on Jun 13, 2000 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 13, 2000 Series Unknown $40.50M 2 Detail
May 17, 1999 Series Unknown $2M 1 BankInvest Biomedical Venture Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Genmab is funded by 2 investors. LODH Immunology Fund and BankInvest Biomedical Venture are the most recent investors.
Investor Name Lead Investor Funding Round
LODH Immunology Fund Series Unknown
BankInvest Biomedical Venture Series Unknown